Volume 13, Number 3—March 2007
Research
In Vitro Cell Culture Infectivity Assay for Human Noroviruses
Figure 4
![Cytopathic effect results from the third infectivity trial. A) Virus-free control of B) combined viral stock lysate from second passage experiment (second infectivity trial, P1), which was used to infect naive cells (P2). C) Virus-free control of the flag2 stool sample. D) Corresponding infection with the flag2 stool sample (P0). E) Flag2 in cell culture (P1). Cells in Panels B, D, and E were confirmed as positive for norovirus by reverse transcription–PCR (RT-PCR) and seminested PCR. Cells in u](/eid/images/06-0549-F4.jpg)
Figure 4. Cytopathic effect results from the third infectivity trial. A) Virus-free control of B) combined viral stock lysate from second passage experiment (second infectivity trial, P1), which was used to infect naive cells (P2). C) Virus-free control of the flag2 stool sample. D) Corresponding infection with the flag2 stool sample (P0). E) Flag2 in cell culture (P1). Cells in Panels B, D, and E were confirmed as positive for norovirus by reverse transcription–PCR (RT-PCR) and seminested PCR. Cells in uninfected controls were negative for norovirus by both RT-PCR and nested PCR. Arrows indicate cells exhibiting unusual pathology.
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.